Long-Term Treatment with Budesonide in Vasomotor Rhinitis

Abstract
Patients (12) entered a long-term study of budesonide [an antiinflammatory steroid] treatment in vasomotor rhinitis. The efficacy of the treatment was studied. Possible systemic side effects were studied via an ACTH stimulation test prior to and during treatment. The local effect in the nasal mucosa was studied by means of a nasal biopsy before and after 1 yr of treatment. The treatment proved effective, producing no systemic or local side effects during a 1-yr treatment period.